Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-21

Clinical Trial Update: Herniorrhaphy Study for Opioid Elimination [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a herniorrhaphy study targeting opioid elimination in analgesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Heron Therapeutics | Conditions: Analgesia | Phase 3 | Status: COMPLETED